The study of Zhang et al. suggested that highly expressed LINC0051 directly interacted with miR-29c to suppress its expression and then promoted the upregulation of CDK6, a direct target of miR-29c, leading to an increase in the cell viability of breast cancer cells [28]. The gene discussed is CDK6; the disease is breast carcinoma.